Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

100%

5 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 3

3(60.0%)

Phase 4

2(40.0%)

5Total

Phase 3(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07732699Phase 4Not Yet Recruiting

Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Sinusitis)

Role: lead

NCT07730814Phase 4Not Yet Recruiting

Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Otitis Media)

Role: lead

NCT02554383Phase 3Completed

Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?

Role: lead

NCT01391793Phase 3Completed

Corticosteroids for Children With Febrile Urinary Tract Infections

Role: lead

NCT02630992Phase 3Completed

Reduced Clavulanate Formulation of Amoxicillin-Clavulanate in Children 6-23 Months With Acute Otitis Media

Role: lead

All 5 trials loaded